CD19 and neoplasm: After the same effector cells were injected into the tail vein, BLI results demonstrated that CLDN6-CAR1 NK cells almost inhibited tumor cell growth or even partially eliminated hepatic tumor cells in most of the mice on day 36, while NC and CD19-CAR NK cells could not control tumor cell progression (Fig. 5G and 5H).